Cumberland Pharmaceutical... (CPIX)
NASDAQ: CPIX
· Real-Time Price · USD
3.13
-0.11 (-3.40%)
At close: Oct 03, 2025, 3:59 PM
3.10
-1.04%
After-hours: Oct 03, 2025, 06:57 PM EDT
-3.40% (1D)
| Bid | 3.09 |
| Market Cap | 46.82M |
| Revenue (ttm) | 42.07M |
| Net Income (ttm) | -2.93M |
| EPS (ttm) | -0.22 |
| PE Ratio (ttm) | -14.23 |
| Forward PE | -5.89 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 3.21 |
| Volume | 18,067 |
| Avg. Volume (20D) | 56,342 |
| Open | 3.23 |
| Previous Close | 3.24 |
| Day's Range | 3.10 - 3.25 |
| 52-Week Range | 1.04 - 7.25 |
| Beta | -0.41 |
| Ex-Dividend Date | n/a |
About CPIX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CPIX
Website n/a
2 months ago
+13.92%
Cumberland Pharmaceuticals shares are trading high...
Unlock content with
Pro Subscription
4 months ago
+9.36%
Cumberland Pharmaceuticals shares are trading higher after the company announced it published a study investigating Caldolor in older patients.
2 months ago · seekingalpha.com
Cumberland Pharmaceuticals Inc. (CPIX) Q2 2025 Earnings Call TranscriptCumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants A. J. Kazimi - Founder, Chairman, President & CEO John Michael Hamm - VP ...